C9orf72 and amyotrophic lateral sclerosis: He et al. (2023) reported that C9orf72 ALS patient-derived NPCs exhibited a significant increase in DNA damage, as indicated by longer comet assay tails even after 24 h recovery period following treatment with ETP compared to healthy controls (p < 0.05).